- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 3 residues within 4Å:- Chain A: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.122, N.125, V.127
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.234
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: E.281, N.282
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: G.339, F.342, N.343
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.1074
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: V.120, N.122, N.125, V.127
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.164, N.165
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.234
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: E.281, N.282
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: G.339, F.342, N.343
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.616, T.618
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.709, G.1131
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.1074
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain D: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain D: V.120, N.122, N.125, V.127
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain D: N.164, N.165
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain D: N.234
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain D: E.281, N.282
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain D: G.339, F.342, N.343
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain D: N.603
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain D: N.616, T.618
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain D: N.657
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain D: N.709, G.1131
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain D: N.1074
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, L., SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody. To Be Published
- Release Date
- 2023-09-13
- Peptides
- Spike glycoprotein: ABD
Heavy chain of R15-F7: CEF
P14 Nanobody: GHI
Light chain of R15-F7: JKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BD
DC
CE
EF
FG
GH
HI
IJ
JK
KL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, L., SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody. To Be Published
- Release Date
- 2023-09-13
- Peptides
- Spike glycoprotein: ABD
Heavy chain of R15-F7: CEF
P14 Nanobody: GHI
Light chain of R15-F7: JKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BD
DC
CE
EF
FG
GH
HI
IJ
JK
KL
L